|
1
|
Foreman B: The pathophysiology of delayed
cerebral ischemia. J Clin Neurophysiol. 33:174–182. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perez-Alvarez A, Navarrete M, Covelo A,
Martin ED and Araque A: Structural and functional plasticity of
astrocyte processes and dendritic spine interactions. J Neurosci.
34:12738–12744. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heuser K, Szokol K and Taubøll E: The role
of glial cells in epilepsy. Tidsskr Nor Laegeforen. 134:37–41.
2014.(In English, Norwegian). View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nesic O, Guest JD, Zivadinovic D, Narayana
PA, Herrera JJ, Grill RJ, Mokkapati VU, Gelman BB and Lee J:
Aquaporins in spinal cord injury: The janus face of aquaporin 4.
Neuroscience. 168:1019–1035. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stokum JA, Kurland DB, Gerzanich V and
Simard JM: Mechanisms of astrocyte-mediated cerebral edema.
Neurochem Res. 40:317–328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Clasadonte J, Dong J, Hines DJ and Haydon
PG: Astrocyte control of synaptic NMDA receptors contributes to the
progressive development of temporal lobe epilepsy. Proc Natl Acad
Sci USA. 110:17540–17545. 2013; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Papadopoulos MC and Verkman AS: Aquaporin
water channels in the nervous system. Nat Rev Neurosci. 14:265–277.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rajkowska G, Hughes J, Stockmeier CA,
Miguel-Hidalgo J Javier and Maciag D: Coverage of blood vessels by
astrocytic endfeet is reduced in major depressive disorder. Biol
Psychiatry. 73:613–621. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mao L, Wang HD, Pan H and Qiao L:
Sulphoraphane enhances aquaporin-4 expression and decreases spinal
cord oedema following spinal cord injury. Brain Inj. 25:300–306.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Q, Zhang YJ, Gao JY, Li XM, Kong H,
Zhang YP, Xiao M, Shields CB and Hu G: Aquaporin-4 mitigates
retrograde degeneration of rubrospinal neurons by facilitating
edema clearance and glial scar formation after spinal cord injury
in mice. Mol Neurobiol. 49:1327–1337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kimura A, Hsu M, Seldin M, Verkman AS,
Scharfman HE and Binder DK: Protective role of aquaporin-4 water
channels after contusion spinal cord injury. Ann Neurol.
67:794–801. 2010.PubMed/NCBI
|
|
12
|
Genc S, Zadeoglulari Z, Oner MG, Genc K
and Digicaylioglu M: Intranasal erythropoietin therapy in nervous
system disorders. Expert Opin Drug Deliv. 8:19–32. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Evaniew N, Noonan VK, Fallah N, Kwon BK,
Rivers CS, Ahn H, Bailey CS, Christie SD, Fourney DR, Hurlbert RJ,
et al: Methylprednisolone for the treatment of patients with acute
spinal cord injuries: A propensity score-matched cohort study from
a Canadian multi-center spinal cord injury registry. J Neurotrauma.
32:1674–1683. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilson JR, Forgione N and Fehlings MG:
Emerging therapies for acute traumatic spinal cord injury. CMAJ.
185:485–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tesiorowski M, Potaczek T, Jasiewicz B,
Sapa J and Zygmunt M: Methylprednisolone-acute spinal cord injury,
benefits or risks? Postepy Hig Med Dosw (Online). 67:601–609.
2013.(In Polish). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chikuda H, Yasunaga H, Takeshita K,
Horiguchi H, Kawaguchi H, Ohe K, Fushimi K and Tanaka S: Mortality
and morbidity after high-dose methylprednisolone treatment in
patients with acute cervical spinal cord injury: A
propensity-matched analysis using a nationwide administrative
database. Emerg Med J. 31:201–206. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jongen PJ, Stavrakaki I, Voet B,
Hoogervorst E, van Munster E, Linssen WH, Sinnige LG, Verhagen WI,
Visser LH, Van Der Kruijk R, et al: Patient-reported adverse
effects of high-dose intravenous methylprednisolone treatment: A
prospective web-based multi-center study in multiple sclerosis
patients with a relapse. J Neurol. 263:1641–1651. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schroeder GD, Kwon BK, Eck JC, Savage JW,
Hsu WK and Patel AA: Survey of cervical spine research society
members on the use of high-dose steroids for acute spinal cord
injuries. Spine (Phila Pa 1976). 39:971–977. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schäfer R, Mueller L, Buecheler R, Proksch
B, Schwab M, Gleiter CH and Danielyan L: Interplay between
endothelin and erythropoietin in astroglia: The role in protection
against hypoxia. Int J Mol Sci. 15:2858–2875. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Merelli A, Czornyj L and Lazarowski A:
Erythropoietin: A neuroprotective agent in cerebral hypoxia,
neurodegeneration, and epilepsy. Curr Pharm Des. 19:6791–6801.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ugurluer G, Cebi A, Mert H, Mert N, Serin
M and Erkal HS: Neuroprotective effects of erythropoietin against
oxidant injury following brain irradiation: An experimental study.
Arch Med Sci. 12:1348–1353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Genc S, Koroglu TF and Genc K:
Erythropoietin and the nervous system. Brain Res. 1000:19–31. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yuen CM, Leu S, Lee FY, Yen CH, Lin YC,
Chua S, Chung SY, Chai HT, Sheu JJ, Ko SF, et al: Erythropoietin
markedly attenuates brain infarct size and improves neurological
function in the rat. J Investig Med. 58:893–904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gorio A, Madaschi L, Di Stefano B, Carelli
S, Di Giulio AM, De Biasi S, Coleman T, Cerami A and Brines M:
Methylprednisolone neutralizes the beneficial effects of
erythropoietin in experimental spinal cord injury. Proc Natl Acad
Sci USA. 102:16379–16384. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Alibai E, Zand F, Rahimi A and
Rezaianzadeh A: Erythropoietin plus methylprednisolone or
methylprednisolone in the treatment of acute spinal cord injury: A
preliminary report. Acta Med Iran. 52:275–279. 2014.PubMed/NCBI
|
|
26
|
Boussicault L, Hérard AS, Calingasan N,
Petit F, Malgorn C, Merienne N, Jan C, Gaillard MC, Lerchundi R,
Barros LF, et al: Impaired brain energy metabolism in the BACHD
mouse model of Huntington's disease: Critical role of
astrocyte-neuron interactions. J Cereb Blood Flow Metab.
34:1500–1510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He L, Zhang X, Wei X and Li Y:
Progesterone attenuates aquaporin-4 expression in an astrocyte
model of ischemia/reperfusion. Neurochem Res. 39:2251–2261. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fairbanks SL, Young JM, Nelson JW, Davis
CM, Koerner IP and Alkayed NJ: Mechanism of the sex difference in
neuronal ischemic cell death. Neuroscience. 219:183–191. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dong W, Xiao S, Cheng M, Ye X and Zheng G:
Minocycline induces protective autophagy in vascular endothelial
cells exposed to an model of ischemia/reperfusion-induced injury.
Biomed Rep. 4:173–177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rao KV, Reddy PV, Curtis KM and Norenberg
MD: Aquaporin-4 expression in cultured astrocytes after fluid
percussion injury. J Neurotrauma. 28:371–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Robertson CS, Cherian L, Shah M, Garcia R,
Navarro JC, Grill RJ, Hand CC, Tian TS and Hannay HJ:
Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a
model of mild traumatic brain injury complicated by hemorrhagic
shock. J Neurotrauma. 29:1156–1166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brissaud O, Villega F, Konsman J Pieter,
Sanchez S, Raffard G, Franconi JM, Chateil JF and Bouzier-Sore AK:
Short-term effect of erythropoietin on brain lesions and
aquaporin-4 expression in a hypoxic-ischemic neonatal rat model
assessed by magnetic resonance diffusion weighted imaging and
immunohistochemistry. Pediatr Res. 68:123–127. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang Z, Sun X, Huo G, Xie Y, Shi Q, Chen
S, Wang X and Liao Z: Protective effects of erythropoietin on
astrocytic swelling after oxygen-glucose deprivation and
reoxygenation: Mediation through AQP4 expression and MAPK pathway.
Neuropharmacology. 67:8–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miljus N, Heibeck S, Jarrar M, Micke M,
Ostrowski D, Ehrenreich H and Heinrich R: Erythropoietin-mediated
protection of insect brain neurons involves JAK and STAT but not
PI3K transduction pathways. Neuroscience. 258:218–227. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kwon MS, Kim MH, Kim SH, Park KD, Yoo SH,
Oh IU, Pak S and Seo YJ: Erythropoietin exerts cell protective
effect by activating PI3K/Akt and MAPK pathways in C6 cells. Neurol
Res. 36:215–223. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Smith PD, Puskas F, Fullerton DA, Meng X,
Cho D, Cleveland JC Jr, Weyant MJ and Reece TB: Attenuation of
spinal cord ischemia and reperfusion injury by erythropoietin. J
Thorac Cardiovasc Surg. 141:256–260. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hwang J, Huh J, Kim J, Jeon Y, Cho S and
Han S: Pretreatment with erythropoietin attenuates the neurological
injury after spinal cord ischemia. Spinal Cord. 50:208–212. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chu H, Ding H, Tang Y and Dong Q:
Erythropoietin protects against hemorrhagic blood-brain barrier
disruption through the effects of aquaporin-4. Lab Invest.
94:1042–1053. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Uzüm G, Diler A Sarper, Bahcekapili N and
Ziylan Y Ziya: Erythropoietin prevents the increase in blood-brain
barrier permeability during pentylentetrazol induced seizures. Life
Sci. 78:2571–2576. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Martinez-Estrada OM, Rodriguez-Millán E,
González-De Vicente E, Reina M, Vilaró S and Fabre M:
Erythropoietin protects the in vitro blood-brain barrier against
VEGF-induced permeability. Eur J Neurosci. 18:2538–2544. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhang C, Chen J and Lu H: Expression of
aquaporin-4 and pathological characteristics of brain injury in a
rat model of traumatic brain injury. Mol Med Rep. 12:7351–7357.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tang G and Yang GY: Aquaporin-4: A
potential therapeutic target for cerebral edema. Int J Mol Sci.
17:pii: E1413. 2016. View Article : Google Scholar
|
|
44
|
Corsini E, Pinto A, Galbiati V, Viviani B,
Galli CL, Marinovich M and Racchi M: Corticosteroids modulate the
expression of the PKC-anchoring protein RACK-1 and cytokine release
in THP-1 cells. Pharmacol Res. 81:10–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang CY, Zhang JX, Lü XT and Li BY:
Effects of intermittent hypoxic exposure on the parameter of
erythrocyte and serum hypoxia inducible factor-1 alpha and
erythropoietin levels. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
25:932–934. 2009.(In Chinese). PubMed/NCBI
|
